The approval was based on data from the POETYK PsA-1 and POETYK PsA-2 trials, which evaluated the efficacy and safety of ...

Tazverik is withdrawn for all indications, including follicular lymphoma and epithelioid sarcoma, following unfavorable trial safety data.

The phase 3 SUCCESSOR-2 trial shows mezigdomide-based therapy improves PFS in R/R multiple myeloma patients previously exposed to lenalidomide.

Data show T-DXd improves invasive disease-free survival and reduces the risk of distant recurrence in early HER2-positive breast cancer.

Cure rate of 42% estimated in cure modeling; highest rate seen for patients with low Follicular Lymphoma International Prognostic Index scores.

Kennedy Jr. announced a new effort Thursday aimed at getting medical schools to spend more time teaching students about nutrition.

HealthDay News — Testosterone replacement therapy (TRT) before total knee arthroplasty (TKA) is associated with an increased risk for medical and periprosthetic complications, according to a study ...

Adults aged 75 years or older should receive an RSV protein subunit vaccine; receipt can be considered for those aged 60 to 74 years at increased risk ...

The FDA is expected to decide on treatments for Alzheimer disease agitation, focal segmental glomerulosclerosis, hematological malignancies, HIV-1, and obesity.

Adults with overweight or obesity regain much of their lost weight after cessation of glucagon-like peptide-1 receptor agonists (GLP-1 RAs), according to a revi ...

School-based cohort had lower risk for cervical cancer compared with the opportunistic cohort after adjustment for covariates.